Jazz Pharmaceuticals: Carr proposes $327K share sale
The notice separately lists 1,250 shares from a stock option exercise and 163 under the Employee Stock Purchase Plan, with cash shown as payment.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Jazz Pharmaceuticals plc (JAZZ) reported a proposed sale of 1,413 common shares for the account of officer Patricia Carr, who signed as Patricia Josephine Carr. The shares have an aggregate market value of $326,909.51. The approximate sale date is November 4, 2026, and NASDAQ is listed as the exchange.
Key Figures
Key Terms
Rule 144 regulatory
aggregate market value financial
Stock Option Exercise financial
Employee Stock Purchase Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.